Havard Bentsen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Neurocognitive effects of an omega-3 fatty acid and vitamins E+C in schizophrenia: A randomised controlled trial.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: January 04, 2017
Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study.
Journal: BMC psychiatry
Published: May 15, 2016
Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia.
Journal: Acta psychiatrica Scandinavica
Published: December 10, 2014
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
Journal: Translational psychiatry
Published: August 07, 2013
Associations between serotonin transporter polymorphisms and cognitive processing applying the Emo 1-back task.
Journal: Cognition & emotion
Published: September 29, 2012
Use of slow-release injections to administer antipsychotic drugs
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: February 09, 2012
Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells.
Journal: Prostaglandins, leukotrienes, and essential fatty acids
Published: January 20, 2012
What will be a "recommended" antipsychotic agent?
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: November 21, 2007
Showing 1-10 of 10
Last Updated: 09/26/2026